title: Use of intramuscular ziprasidone for the control of acute psychosis or agitation in an inpatient geriatric population: an open-label study.
abstract: Objective. This open-label study examined the safety and efficacy of ziprasidone intramuscular with geriatric patients experiencing psychosis or agitation.Design. During an inpatient stay, consenting subjects who became acutely psychotic or agitated received ziprasidone intramuscular 10mg q 6 to 8 hours, up to a maximum dose of 20mg/24 hours. A within-group repeated measures design was employed to study whether the use of ziprasidone over the 24-hour observation period contributed to decreased agitation or to extrapyramidal side effects. The data were analyzed using an Analysis of Variance with trend analysis.Setting. The study was conducted on the geriatric psychiatry inpatient unit at the University of Toledo Medical Center, Toledo, Ohio.Participants. Fourteen patients, six men and eight women with mean age 77+/-8 years, participated in this study. Each patient had a diagnosis of dementia, co-occurring with one of the following: delirium, major depressive disorder with psychotic features, schizophrenia, bipolar disorder, or schizoaffective disorder.Measurements. The Brief Psychiatric Rating Scale, Delirium Rating Scale, and the Behavioral Activity Rating Scale were obtained at baseline and at 0.5, 2, and 24 hours after the first dose of ziprasidone intramuscular.Results. Overall, physiologic measures that would indicate undesirable side effects, including QTc intervals, remained unchanged pre- and post-study. However, there were significant improvements in scores on a variety of measures assessing agitation or psychosis.Conclusion. This study suggests that ziprasidone intramuscular may be a safe and effective short-term treatment for agitated or psychotic geriatric patients, and, therefore, additional studies should be conducted to confirm these findings.
authors.affiliation: Dr. Alina Rais is Associate Professor, Director Psychogeriatric Program of the University of Toledo Medical Center (UTMC), Toledo, Ohio.
authors.forename: Alina R
authors.initials: AR
authors.lastname: Rais
authors.forename: Kristi
authors.initials: K
authors.lastname: Williams
authors.forename: Theodor
authors.initials: T
authors.lastname: Rais
authors.forename: Tanvir
authors.initials: T
authors.lastname: Singh
authors.forename: Marijo
authors.initials: M
authors.lastname: Tamburrino
references.citation: Psychiatry Res. 1988 Jan;23(1):89-97
references.pmid: 3363018
references.citation: J Clin Psychopharmacol. 1998 Aug;18(4):296-304
references.pmid: 9690695
references.citation: J Clin Psychiatry. 2000 Dec;61(12):933-41
references.pmid: 11206599
references.citation: CNS Spectr. 2005 Sep;10(9):1-15
references.pmid: 16247923
references.citation: Int Clin Psychopharmacol. 2001 Jan;16 Suppl 1:S15-9
references.pmid: 11252523
references.citation: J Am Geriatr Soc. 1993 Jan;41(1):50-2
references.pmid: 8418123
references.citation: Am J Geriatr Pharmacother. 2005 Dec;3(4):240-5
references.pmid: 16503319
references.citation: Br J Psychiatry. 1989 May;154:672-6
references.pmid: 2574607
references.citation: Psychosomatics. 2002 Jan-Feb;43(1):61-2
references.pmid: 11927760
references.citation: Int J Psychiatry Med. 2005;35(1):91-8
references.pmid: 15977947
references.citation: J Psychiatr Res. 2002 Mar-Apr;36(2):87-95
references.pmid: 11777497
references.citation: J Psychiatr Pract. 2002 Mar;8(2):81-97
references.pmid: 15985861
references.citation: CNS Drugs. 2002;16(4):219-28
references.pmid: 11945106
references.citation: J Am Med Dir Assoc. 2009 Jan;10(1):21-7
references.pmid: 19111849
references.citation: Psychopharmacology (Berl). 2001 May;155(2):128-34
references.pmid: 11401000
references.citation: Psychopharmacology (Berl). 1998 Nov;140(2):173-84
references.pmid: 9860108
references.citation: Clin Neuropharmacol. 2005 May-Jun;28(3):111-4
references.pmid: 15965308
references.citation: Psychiatr Q. 2002 Winter;73(4):297-311
references.pmid: 12418358
references.citation: CNS Drugs. 2002;16(1):23-45
references.pmid: 11772117
references.citation: Eur Psychiatry. 2006 Dec;21(8):578-9
references.pmid: 16139485
references.citation: Dement Geriatr Cogn Disord. 2006;22(5-6):445-8
references.pmid: 16983187
references.citation: J Clin Psychiatry. 2005 Jul;66(7):928-9
references.pmid: 16013910
references.citation: Hum Psychopharmacol. 2005 Apr;20(3):203-5
references.pmid: 15799011
references.citation: Am J Geriatr Psychiatry. 2006 Jul;14(7):629-33
references.pmid: 16816018